GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » YoY EPS Growth

Progen Co (XKRX:296160) YoY EPS Growth : 56.13% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Progen Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Progen Co's YoY EPS Growth for the quarter that ended in Dec. 2024 was 56.13%.

Progen Co's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was ₩-547.00.

Progen Co YoY EPS Growth Historical Data

The historical data trend for Progen Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progen Co YoY EPS Growth Chart

Progen Co Annual Data
Trend Dec23 Dec24
YoY EPS Growth
- 56.13

Progen Co Semi-Annual Data
Dec23 Dec24
YoY EPS Growth - 56.13

Progen Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Progen Co's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EPS Growth (A: Dec. 2024 )
=(Earnings per Share (Diluted) (A: Dec. 2024 )-Earnings per Share (Diluted) (A: Dec. 2023 ))/ | Earnings per Share (Diluted) (A: Dec. 2023 ) |
=(-547--1247)/ | -1247 |
=56.13 %

Progen Co's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EPS Growth (Q: Dec. 2024 )
=(Earnings per Share (Diluted) (Q: Dec. 2024 )-Earnings per Share (Diluted) (Q: Dec. 2023 )) / | Earnings per Share (Diluted) (Q: Dec. 2023 ) |
=(-547--1247)/ | -1247 |
=56.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Progen Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Progen Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Progen Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » YoY EPS Growth
Comparable Companies
XKRX:222110 XKRX:299660 XKRX:348080 XKRX:261780 XKRX:038070 XKRX:308080 XKRX:168330 XKRX:383930 XKRX:046210 XKRX:456570 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
172 Magokjungang-ro, 7th Floor, Bio Innovation Park, Gangseo-gu, Seoul, KOR
Website
http://www.progen.co.kr
Progen Co Ltd is an R&D focused biopharmaceutical development venture. It is engaged in developing metabolic disease treatments, immune disease treatments, and immune anti cancer drugs using its immunology based drug development know how, and is focusing on developing inventive drugs through domestic and international open innovation.

Progen Co Headlines

No Headlines